Suppr超能文献

鉴定肾组织中的组织蛋白酶B作为人肾素原加工酶。

Identification of renal cathepsin B as a human prorenin-processing enzyme.

作者信息

Wang P H, Do Y S, Macaulay L, Shinagawa T, Anderson P W, Baxter J D, Hsueh W A

机构信息

Department of Medicine, Los Angeles County, Medical Center 90033.

出版信息

J Biol Chem. 1991 Jul 5;266(19):12633-8.

PMID:2061332
Abstract

Prorenin, the inactive biosynthetic precursor of renin, is proteolytically cleaved in the renal juxtaglomerular cells to renin. The activity of renin is rate-limiting for generation of angiotensin II in the circulation. We identified a renal thiol protease which activates and accurately cleaves the 43-amino acid prosegment of human recombinant prorenin. In the current studies, 6.5 mg of this protease was purified from human renal cortex using a three-step procedure dependent upon Leu-Leu-arginyl affinity chromatography. This represented an overall 766-fold purification and resulted in three protein bands on sodium dodecyl sulfate-polyacrylamide gel electrophoresis of molecular weights 30,000, 25,000, and 24,000. All three bands cross-reacted with an anti-human liver cathepsin B antibody upon immunoblot analysis; electrolution of each band and amino-terminal sequence analysis confirmed that the Mr 30,000 protein was mature cathepsin B and the Mr 25,000 and 24,000 bands were cathepsin B subunits. The pH optimum for the hydrolysis of pure human recombinant prorenin by pure renal cathepsin B was 6, and the Michaelis-Menten constant, Km, of the reaction was 1.4 x 10(-9) M. Immunostaining of human kidney using a sheep anti-human cathepsin B antibody demonstrated the presence of cathepsin B in the juxtaglomerular areas of the kidney, as well as in the renal proximal tubules. Electron microscopic immunohistochemistry using the same antibody demonstrated cathepsin B in dense secretory granules of the juxtaglomerular cells. Renin was also shown to be present in these granules. This study provides both biochemical and morphological evidence that renal cathepsin B is a human prorenin-processing enzyme.

摘要

肾素原是肾素的无活性生物合成前体,在肾近球细胞中被蛋白水解切割成肾素。肾素的活性是循环中血管紧张素II生成的限速因素。我们鉴定出一种肾硫醇蛋白酶,它可激活并准确切割人重组肾素原的43个氨基酸的前肽段。在当前研究中,使用依赖亮氨酸-亮氨酸-精氨酰亲和层析的三步法从人肾皮质中纯化出6.5毫克这种蛋白酶。这代表了总体766倍的纯化,并且在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳上产生了分子量为30,000、25,000和24,000的三条蛋白带。免疫印迹分析时,所有三条带均与抗人肝组织蛋白酶B抗体发生交叉反应;对每条带进行电洗脱和氨基末端序列分析证实,分子量为30,000的蛋白是成熟的组织蛋白酶B,分子量为25,000和24,000的带是组织蛋白酶B亚基。纯肾组织蛋白酶B水解纯人重组肾素原的最适pH为6,该反应的米氏常数Km为1.4×10⁻⁹M。使用羊抗人组织蛋白酶B抗体对人肾进行免疫染色显示,在肾的近球区域以及肾近端小管中存在组织蛋白酶B。使用相同抗体的电子显微镜免疫组织化学显示,组织蛋白酶B存在于近球细胞的致密分泌颗粒中。肾素也显示存在于这些颗粒中。本研究提供了生化和形态学证据证明肾组织蛋白酶B是一种人肾素原加工酶。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验